# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-20-043004
Filing Date
2020-12-16
Accepted
2020-12-16 16:05:32
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2020_citiuspharma.htm | 10-K | 1066120
2 | LICENSE AGREEMENT, DATED OCTOBER 6, 2020, BETWEEN NOVECITE, INC. AND NOVELLUS TH | f10k2020ex10-24_citius.htm | EX-10.24 | 413257
3 | SUBSIDIARIES | f10k2020ex21_citius.htm | EX-21 | 9169
4 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | f10k2020ex23-1_citius.htm | EX-23.1 | 3757
5 | CERTIFICATION | f10k2020ex31-1_citius.htm | EX-31.1 | 12651
6 | CERTIFICATION | f10k2020ex31-2_citius.htm | EX-31.2 | 12994
7 | CERTIFICATION | f10k2020ex32-1_citius.htm | EX-32.1 | 7144
| Complete submission text file | 0001213900-20-043004.txt |  | 4414796

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL INSTANCE FILE | ctxr-20200930.xml | EX-101.INS | 484751
9 | XBRL SCHEMA FILE | ctxr-20200930.xsd | EX-101.SCH | 56739
10 | XBRL CALCULATION FILE | ctxr-20200930_cal.xml | EX-101.CAL | 43937
11 | XBRL DEFINITION FILE | ctxr-20200930_def.xml | EX-101.DEF | 164067
12 | XBRL LABEL FILE | ctxr-20200930_lab.xml | EX-101.LAB | 340713
13 | XBRL PRESENTATION FILE | ctxr-20200930_pre.xml | EX-101.PRE | 261847

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-38174 | Film No.: 201392479
SIC: 2834 Pharmaceutical Preparations